patent/CN-101686988-B

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101686988-B

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4841 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
filingDate	2008-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate	2013-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f51f3b23945342cdbe1aaa2815494dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ba0c0a71a4d06201dc1ef7d8663a537 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40accd5c56365a8cdc258104df723695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82ea4836ce795f45080fe59109c3e085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ef40d1ee23ecc825db95b9fa24a9e38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0038aac05998fd86d422d81eef8357e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d679e72e39c4e3dd58ce835f7cdd6fba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7702797695ac6f0938af37090c2d847e
publicationDate	2013-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-101686988-B
titleOfInvention	Pharmaceutical preparations containing dapagliflozin propylene glycol hydrate
abstract	The present invention provides a pharmaceutical preparation in the form of capsules or tablets for oral administration, comprising dapagliflozin propylene glycol hydrate of formula (Ia) or formula (Ib) and a pharmaceutically acceptable carrier, the preparation is designed for immediate release. The formulation is used in the treatment of diabetes and related diseases.
priorityDate	2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467877963 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24807437 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421423193

Total number of triples: 50.